Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?

Journal of Research in Medical Sciences

Volumn 17, Issue 11, 2012, Pages 1005-1010

  Salehidoost, Rezvan ^a   Aminorroaya, Ashraf ^a   Zare, Maryam ^a   Amini, Massoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Insulin resistance; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MERCURY SPHYGMOMANOMETER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84875084160     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
2. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004;4:9.
3. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 2009;48:1785-91.
4. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19:1055-62.
5. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: Results from a single hospital database. Metabolism 2008;57:71-6.
6. Rodrigues SL, Baldo MP, Capingana P, Magalhães P, Dantas EM, Molina Mdel C, et al. Gender distribution of serum uric acid and cardiovascular risk factors: Population based study. Arq Bras Cardiol 2012;98:13-21.
7. Hwu CM, Lin KH. Uric acid and the development of hypertension. Med Sci Monit 2010;16:RA224-30.
8. Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG. Association of serum uric acid with different levels of glucose and related factors. Chin Med J (Engl) 2011;124:1443-8.
9. Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Memon L, Zeljkovic A, Bogavac-Stanojevic N, et al. High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis 2009;203:236-42.
10. Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, FrittittaL, et al. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis 2008;18:624-31.
11. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. JClin Endocrinol Metab 1994;78:25-9.
12. Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M, et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One 2011;6:e19901.
13. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-72.
14. Zavaroni I, Bonini L, Fantuzzi M, Dall'Aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity, and syndrome X. JIntern Med 1994;235:51-6.
15. Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR, Groop LC. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995;38:363-9.
16. Vaag A, Lehtovirta M, Thye-Rönn P, Groop L, European Group of Insulin Resistance. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR). Diabet Med 2001;18:533-40.
17. Florez H, Ryder E, Campos G, Fernandez V, Morales LM, Valbuena H, et al. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin 1999;40:127-42.
18. Norton K, Whittingham N, Carter L, Kerr D, Gore CJ, Marfell-Jones M. Measurement techniques in anthropometry. In: Norton K, Olds T, editors. Anthropometrica: AText-book of Body Measurement for Sports and Health Courses. Sydney: University of New South Wales; 1996. p.25-75.
19. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005;23:697-701.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003;61:29-37.
22. Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS. Impact of metabolic syndrome risk factors in first-degree relatives of type2 diabetic patients. Rev Diabet Stud 2007;4:177-84.
23. Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethn Dis 2006;16:830-6.
24. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-11.
25. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997;46:1162-5.
26. Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: Visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998;47:929-33.
27. Yamashita S, Nakamura T, Shimomura I, Nishida M, Yoshida S, Kotani K, et al. Insulin resistance and body fat distribution. Diabetes Care 1996;19:287-91.
28. Kahn BB, Flier JS. Obesity and insulin resistance. JClin Invest 2000;106:473-81.
29. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfützner A. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999;48:677-80.
30. Bandaru P, Shankar A. Association between Serum Uric Acid Levels and Diabetes Mellitus. Int J Endocrinol 2011;2011:604715.
31. Cai XL, Han XY, Ji LN. Association between serum uric acid and different states of glucose metabolism and glomerular filtration rate. Chin Med J (Engl) 2010;123:3118-22.